Range
8.4 - 8.88
Vol / Avg.
310.4K/5.3M
Div / Yield
-
52 Wk
2.93 - 13.1
Mkt Cap
239.3M
Payout Ratio
-
Open
8.5
P/E
-
EPS
-0.64
Shares
27.7M
Outstanding
27.7M
Total Float
25.5M
load more
Sector: Health Care.Industry: Biotechnology
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways. Its focus is on the extracellular functionality and signaling pathways of tRNA synthetases. It's lead clinical product candidate, ATYR1923, is a selective modulator of Neuropilin-2 (NRP2) that downregulates both the innate and adaptive immune responses in inflammatory disease states. It is developing ATYR1923 as a potential disease-modifying therapy for patients with interstitial lung diseases (ILDs), a group of rare immune-mediated disorders that cause progressive fibrosis of the lung interstitium and remain a high unmet medical need.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-11-11
REV
Q2 2021Est.ActualSurprise
EPS-0.510-0.640 -0.1300
REV620.000K0-620.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

aTyr Pharma Questions & Anwsers

Q

How do I buy aTyr Pharma (LIFE) stock?

A

You can purchase shares of aTyr Pharma (NASDAQ: LIFE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are aTyr Pharma's (LIFE) competitors?

Q

What is the target price for aTyr Pharma (LIFE) stock?

A

The latest price target for aTyr Pharma (NASDAQ: LIFE) was reported by RBC Capital on October 12, 2021. The analyst firm set a price target for 22.00 expecting LIFE to rise to within 12 months (a possible 154.63% upside). 8 analyst firms have reported ratings in the last year.

Q

Current Stock Price for aTyr Pharma (LIFE)?

A

The stock price for aTyr Pharma (NASDAQ: LIFE) is $8.64 last updated Wed Oct 27 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does aTyr Pharma (LIFE) pay a dividend?

A

There are no upcoming dividends for aTyr Pharma.

Q

When is aTyr Pharma (NASDAQ:LIFE) reporting earnings?

A

aTyr Pharma’s $Q3 earnings are confirmed for after-market on $November 11, 2021.

Q

Is aTyr Pharma (LIFE) going to split?

A

There is no upcoming split for aTyr Pharma.

Q

What sector and industry does aTyr Pharma (LIFE) operate in?

A

aTyr Pharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.